STEVEN SIMS: Open Payments
NPI 1316302151 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 107 payments from 19 companies in 2025. Trend: 2023 $462 · 2024 $1,441 · 2025 $1,975
Food & beverage: $1,792Education: $183
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $365 |
| Viatris Specialty LLC | 24 | $328 |
| Insmed, Inc. | 20 | $215 |
| Regeneron Healthcare Solutions, Inc. | 6 | $189 |
| Grifols USA, LLC | 9 | $162 |
| Actelion Pharmaceuticals US, Inc. | 4 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Electromed, Inc. | 4 | $67 |
| Verona Pharma, Inc. | 3 | $62 |
Products named: YUPELRI, DUPIXENT, TRELEGY ELLIPTA, Arikayce, Prolastin-C Liquid, NUCALA, UPTRAVI, OFEV.
Industry payments across CA — which companies pay providers there.
